Amit Deshpande

Title: Innovations by Amit Deshpande in Gene Expression

Introduction

Amit Deshpande is an accomplished inventor based in Cambridge, MA (US). He has made significant contributions to the field of gene expression, particularly in relation to ICOS expression levels. His work has implications for treatment methods that utilize gene signatures to determine ICOS expression in patients.

Latest Patents

Amit Deshpande holds a patent titled "Gene signatures for determining ICOS expression." This patent provides gene expression signatures that correlate with ICOS expression levels. It also outlines methods of treatment that involve determining ICOS expression levels using these gene signatures and administering anti-ICOS antibodies to patients.

Career Highlights

Amit Deshpande is currently employed at Jounce Therapeutics, Inc., where he continues to advance research in immunotherapy and gene expression. His innovative work has positioned him as a key figure in the development of new therapeutic strategies.

Collaborations

Amit collaborates with notable colleagues, including Jason Windham Reeves and Igor Feldman. Their combined expertise enhances the research efforts at Jounce Therapeutics, Inc.

Conclusion

Amit Deshpande's contributions to gene expression and ICOS expression levels represent a significant advancement in the field of immunotherapy. His innovative patent and ongoing work at Jounce Therapeutics, Inc. highlight his role as a leading inventor in this important area of research.